Weekly Recap: Barclays cuts price target and Q3 revenue declines
Beyond Meat reported Q3 gross profit of $12.4M, up from $5.2M YoY, with gross margin rising to 19.3%. U.S. and international revenues fell 12.3% and 2.8%, respectively. Barclays maintained its Underweight rating and cut its price target to $5 from $10.
How this was made

The 30-second read
Why it matters
The downgrade and price‑target cut suggest a bearish outlook, potentially prompting short positions or profit‑taking.
Market read
Earnings miss and analyst downgrade create short‑term downside risk for BYND and may influence sentiment in the alternative‑protein space.
What to watch
Cost reductions and international retail growth may offset short‑term volume declines.
Background
Beyond Meat is a publicly traded plant‑based meat substitute producer (NASDAQ: BYND). The article summarizes its Q3 results and a Barclays analyst downgrade.
Ticker impact
Beyond Meat reported Q3 gross profit and margin improvements, but sales volume fell and Barclays cut its price target to $5.
likely pressure as the market prices in the lower price target and weaker sales volume.
The combination of falling sales volume and a 50% price‑target cut signals short‑term downside risk.
Market effects
Plant‑based protein sector may see broader scrutiny as analysts tighten targets.
U.S. consumer‑discretionary stocks could face modest sell pressure.
Limited to investors tracking alternative protein companies.
Counterpoint
Margin expansion could indicate a path to profitability if volume rebounds.
Key entities
- analystBarclays
Maintained Underweight rating and cut price target.


